MyAverix Finance
US · Healthcare
Nymox Pharmaceutical Corporation (NYMXF)
Biotechnology
Nymox Pharmaceutical Corporation (NYMXF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NYMXF
Nymox Pharmaceutical Corporation (NYMXF) — FAQ
What is NYMXF's P/E ratio?
The price-to-earnings (P/E) ratio for Nymox Pharmaceutical Corporation (NYMXF) is 18.00 (data as of 2026-03-24).
Does Nymox Pharmaceutical Corporation pay a dividend?
Dividend yield is not available in the current snapshot for Nymox Pharmaceutical Corporation (NYMXF). Check the MyAverix Finance app for the latest dividend data.
What sector is Nymox Pharmaceutical Corporation in?
Nymox Pharmaceutical Corporation (NYMXF) is classified in the Healthcare sector (Biotechnology industry).
What exchange is NYMXF listed on?
NYMXF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.